Beam Therapeutics Inc. (BEAM) Financials

BEAM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.5 billion 478.4 million
2023-09-30 1.3 billion 511.6 million
2023-06-30 1.4 billion 542.2 million
2023-03-31 1.3 billion 570.8 million

BEAM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 131.5 million 22.6 million
2023-09-30 -97.7 million 25.8 million
2023-06-30 -100.8 million 26.3 million
2023-03-31 -115.8 million 23.9 million

BEAM Net Income

No data available :(

BEAM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.2 billion - 172.7 million
2023-09-30 1.0 billion - 172.6 million
2023-06-30 1.1 billion - 175.3 million
2023-03-31 1.1 billion - 176.5 million

BEAM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 82.7 million
2023-09-30 79.0 million
2023-06-30 76.3 million
2023-03-31 72.3 million

BEAM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 3.6 million 140.1 million 43.3 million -5.4 million
2023-09-30 7.9 million 100.1 million 25.4 million -
2023-06-30 16.2 million 97.6 million 24.7 million -
2023-03-31 6.0 million 99.6 million 23.5 million -

BEAM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 316.2 million 5.4 million
2023-09-30 17.2 million 7.5 million
2023-06-30 20.1 million 7.3 million
2023-03-31 24.2 million 7.0 million

BEAM

Price: $21.74

52 week price:
16.95
49.50

Payout Ratio Range:
-36.16%
50.00%

Earnings Per Share: -1.72 USD

P/E Ratio: -6.97

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.0 million

Market Capitalization: 2.2 billion

Average Dividend Frequency: 4

Links: